GlaxoSmithKline

Not verified. Claim this page

Visit Website

GlaxoSmithKline Sustainability Profile

Sustainability Summary

  • Good On You - Not found
  • Ethical Consumer - This information is locked, visit Ethical Consumer's website
  • B Corp - Not found
  • Trustpilot - 1.5/5 (40 reviews)
  • This is an unclaimed profile. GlaxoSmithKline has not joined Sustainability Tracker to verify their sustainability credentials. We gathered what we could from public sources.
Powered by Tracker AI BETA; there may be errors 
GlaxoSmithKline (GSK) says responsible business is part of its strategy and culture. It groups its work into six areas: access, global health and health security, environment, inclusion, ethical standards, and product governance. On the environment side, it says it is working toward a net zero, nature positive, healthier planet, with goals for 2030 and 2045. GSK also says it wants to improve access to medicines, support inclusion, and keep strong standards for how it works with suppliers and other partners. Independent third-party material in the scraped content is limited, so most of the detail comes from GSK’s own disclosures.

Positive Sentiment Found
Public sentiment in the material is limited, but there are a few positive signals. GSK’s own responsibility pages present a broad responsible business framework, with six focus areas and stated goals on access, inclusion, ethics, and the environment. A third-party article from Nexthink describes GSK as using technology to cut energy use, improve recycling, and reduce manufacturing emissions, and it highlights the company’s new London headquarters as a low-impact, energy-efficient building with a vertical farm. The Commons Earth also includes GSK in a brand-discovery context, but it does not provide a direct sustainability rating for the company in the content shown. Overall, the positive picture is mostly based on GSK’s own disclosures, with some supportive press-style coverage rather than independent scoring.

About GlaxoSmithKline

  • Status
  • Unverified

GlaxoSmithKline Sustainability Actions

Responsible business framework

GSK says responsible business is built into its strategy and culture. It groups its work into six focus areas: access, global health and health security, environment, inclusion, ethical standards, and product governance. In plain terms, this means the company says it tries to think about social, environmental, and governance issues while running the business, not as a side project. It also says this approach helps long-term performance, reduces risk, and supports trust with stakeholders.

3 8 12 13 16

Net zero and nature goals

GSK says it is working toward a net zero, nature positive, healthier planet, with ambitious goals for 2030 and 2045. Net zero means cutting greenhouse gas emissions as much as possible and balancing the rest. Nature positive means trying to improve the state of nature rather than just reduce harm. The company does not give full details in the material shown here, but it clearly treats environmental action as a major part of its responsible business plan.

13 15

Access to medicines

GSK says it aims to make its products available as widely as possible through responsible pricing, strategic access programmes, and partnerships. This is part of its access focus area. In simple terms, the company says it wants more people to be able to get the medicines and vaccines it makes, including in places where cost or supply can be a barrier.

3 10

Product governance and supply

GSK says product governance is one of its six focus areas and that it works to ensure the quality, safety, and reliable supply of its products. That means it says it has systems in place to help make sure medicines and vaccines are made and delivered in a controlled way. This is important in healthcare because poor quality or unstable supply can affect patient safety and access.

3 12

Inclusion and research

GSK says it wants to meet patients’ needs with research that includes people affected by the disease being studied, and it also says it wants to attract and keep talent from different backgrounds. In plain language, it is saying that research should reflect the people it is meant to help, and that the company wants a workforce where people can thrive regardless of background.

3 5 8 10
See All (9)

GlaxoSmithKline Sustainability Commitments

2030

2030 environment goals

GSK says it has ambitious environmental goals for 2030. The page shown here does not list the full targets, but it clearly states that 2030 is a key milestone in its plan to become net zero and nature positive. Because the exact targets are not visible in the material provided, the commitment can only be described at a high level here.

2045

Long-term climate and nature plan

GSK says it is working toward a net zero, nature positive, healthier planet by 2045. Net zero means cutting emissions as far as possible and balancing the rest, while nature positive means aiming to improve nature over time. This is a long-term commitment, but the source shown here does not give the full pathway or interim steps.

2030

Health impact for 2.5 billion

GSK says its plan shows it can positively impact the health of 2.5 billion people worldwide over the next 10 years. This is a future target linked to its purpose and strategy. The statement is broad, so it should be read as an ambition about reach and health impact rather than a detailed operational target.

Is GlaxoSmithKline Sustainable? info Welcome to Sustainability Tracker! Click to learn more.

About GlaxoSmithKline

  • Status
  • Unverified

Sustainable Development Goals

GlaxoSmithKline is committed to advancing these Global Goals to promote prosperity for people & planet.

Logo

Logo

Logo

Logo

Logo

Logo

Logo

Logo

Logo

Logo

Logo

Logo

This information references https://au.gsk.com/en-au/home/ and was sourced on 02/05/2024. Is this your business? Suggest an edit

Frequently Asked Questions

Has GlaxoSmithKline published a sustainability report?

Confidence: Moderate. As of September 2026, GlaxoSmithKline has published responsibility and sustainability-related information on its website, including a page on responsible business and separate pages for environment and inclusion. The material shown here does not include a full standalone sustainability report or a downloadable report file. It does, however, set out six focus areas and says the company is working toward net zero and nature positive goals. Consumers who want the full report trail can check GSK’s responsibility pages and investor or annual reporting pages for more detail.. Sources: GSK Responsibility, GSK Australia home - https://au.gsk.com/en-au/responsibility, https://au.gsk.com/en-au

What is GlaxoSmithKline's sustainability rating?

Confidence: Low. As of September 2026, no clear third-party sustainability rating for GlaxoSmithKline appears in the material shown here. The only review score in the scraped content is a Trustpilot score for haleon.com, which is not GSK’s own sustainability rating and is not a formal ESG assessment. GSK’s own website describes its responsible business approach, but self-published claims are not the same as an independent rating. Consumers looking for a verified score should check major rating bodies directly and ask GSK for any current external assessments.. Sources: Trustpilot, GSK Responsibility - https://ie.trustpilot.com/review/haleon.com, https://au.gsk.com/en-au/responsibility

What sustainability certifications does GlaxoSmithKline have?

Confidence: Low. As of September 2026, no sustainability certification for GlaxoSmithKline is clearly shown in the material provided. The content mentions a B Corp page from B Lab, which explains the certification system, but it does not show GSK as a certified B Corp. The material also does not show ISO 14001, GOTS, or similar certifications for GSK. If a consumer wants to verify certifications, the safest step is to ask GSK directly for current third-party certificates and the sites or facilities they cover.. Sources: B Corp, GSK Responsibility - https://www.bcorporation.net/, https://au.gsk.com/en-au/responsibility

What is GlaxoSmithKline doing about climate and emissions?

Confidence: Moderate. As of September 2026, GlaxoSmithKline says it is working toward a net zero, nature positive, healthier planet, with goals for 2030 and 2045. Net zero means cutting greenhouse gas emissions as much as possible and balancing the rest. A third-party article also says GSK is using technology to monitor energy use, improve recycling, and reduce the carbon footprint of manufacturing. The material shown here does not provide a full emissions inventory or Scope 1, 2, and 3 breakdown, so the exact footprint is not publicly available in this content.. Sources: GSK Responsibility, Nexthink article - https://au.gsk.com/en-au/responsibility, https://nexthink.com/fr/blog/supercharging-sustainability-gsks-tech-driven-leap-toward-a-greener-future

Is GlaxoSmithKline's packaging sustainable?

Confidence: Low. As of September 2026, the material shown here does not give enough public detail to judge whether GlaxoSmithKline’s packaging is sustainable. GSK does say it works on product governance and reliable supply, and a third-party article mentions recycling processes and greener inhaler propellants, but that is not the same as a full packaging disclosure. There is no clear information here on recycled content, recyclability, or packaging reduction targets. Consumers who care about this should ask GSK for packaging data by product line.. Sources: GSK Responsibility, Nexthink article - https://au.gsk.com/en-au/responsibility, https://nexthink.com/fr/blog/supercharging-sustainability-gsks-tech-driven-leap-toward-a-greener-future

Is GlaxoSmithKline ethical on labour and supply chain issues?

Confidence: Moderate. As of September 2026, GSK says ethical standards are one of its six responsible business areas, and it also says product governance covers quality, safety, and reliable supply. It says it wants to conduct itself properly and expects the same from those it works with. That is a positive sign, but the material shown here does not include independent labour audits, supplier scorecards, or detailed supply-chain findings. So the public evidence is mostly GSK’s own description of its approach, not outside verification.. Sources: GSK Responsibility - https://au.gsk.com/en-au/responsibility

What is GlaxoSmithKline doing about sustainability overall?

Confidence: High. As of September 2026, GlaxoSmithKline says sustainability is part of its responsible business strategy. It groups its work into six areas: access, global health and health security, environment, inclusion, ethical standards, and product governance. It also says it is working toward net zero and nature positive goals, wants to improve access to medicines, and is using technology to reduce environmental impact in operations. The main gap is that the material shown here gives broad goals, but not a full independent scorecard or detailed progress data.. Sources: GSK Responsibility, GSK Australia home, Nexthink article - https://au.gsk.com/en-au/responsibility, https://au.gsk.com/en-au, https://nexthink.com/fr/blog/supercharging-sustainability-gsks-tech-driven-leap-toward-a-greener-future